A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2023.2171986
Abstract: ABSTRACT Introduction Clostridiodes difficile infection (CDI) is a life-threatening illness that has been labelled as an urgent threat by the Centers for Disease prevention (CDC). Areas Covered RBX2660, a live biotherapeutic product offers a very… read more here.
Keywords: live biotherapeutic; infection; rbx2660; biotherapeutic product ... See more keywords